Article
Loss of mitochondrial ClpP, Lonp1, and Tfam triggers transcriptional induction of Rnf213, a susceptibility factor for moyamoya disease.
Neurogenetics - 1 Jul 2020
Key Jana, Maletzko Antonia, Kohli Aneesha, Gispert Suzana, Torres-Odio Sylvia, Wittig Ilka, Heidler Juliana, Bárcena Clea, López-Otín Carlos, Lei Yuanjiu, West A Phillip, Münch Christian, Auburger Georg
Abstract excerpt
Human RNF213, which encodes the protein mysterin, is a known susceptibility gene for moyamoya disease (MMD), a cerebrovascular condition with occlusive lesions and compensatory angiogenesis. Mysterin mutations, together with exposure to environmental trigger factors, lead to an elevated stroke risk since childhood. Mysterin is induced during cell stress, to function as cytosolic AAA+ ATPase and ubiquitylation...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
